• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管腔内血运重建术后外周动脉疾病患者的主要不良事件:一项回顾性研究

Major Adverse Events in Patients with Peripheral Artery Disease after Endovascular Revascularization: A Retrospective Study.

作者信息

Kim Mihui, Yang Yong Sook, Ko Young-Guk, Choi Mona

机构信息

College of Nursing, Brain Korea 21 FOUR Project, Yonsei University, Seoul 03722, Korea.

Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul 03722, Korea.

出版信息

J Clin Med. 2022 May 1;11(9):2547. doi: 10.3390/jcm11092547.

DOI:10.3390/jcm11092547
PMID:35566674
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9102344/
Abstract

OBJECTIVE

For peripheral artery disease (PAD) patients, after endovascular revascularization, it is crucial to manage associated factors that can affect the risk of major adverse events. We aimed to investigate the associated factors of major adverse events in these patients.

MATERIALS AND METHODS

We conducted a retrospective longitudinal analysis using the electronic medical records from a tertiary hospital in Korea and included the data of 1263 patients. Eligible patients were categorized into four groups based on diabetes mellitus (DM) and regular exercise. The major adverse events included major adverse limb events and major adverse cardiovascular events. Major adverse events-free survival was assessed using the Kaplan-Meier method, and associated factors of major adverse events were analyzed using Cox proportional hazards analyses.

RESULTS

Kaplan-Meier survival curves showed that patients with DM and non-regular exercise had a shorter major adverse events-free survival. The Cox regression analysis showed that for patients with critical limb ischemia or chronic kidney disease, the risk of major adverse events increased, while group variables were not significant.

CONCLUSION

Target management of patients with DM, critical limb ischemia, and chronic kidney disease is essential to reduce major adverse events after endovascular revascularization in patients with PAD.

摘要

目的

对于外周动脉疾病(PAD)患者,血管内血运重建术后,控制可能影响主要不良事件风险的相关因素至关重要。我们旨在调查这些患者主要不良事件的相关因素。

材料与方法

我们使用韩国一家三级医院的电子病历进行了一项回顾性纵向分析,纳入了1263例患者的数据。符合条件的患者根据糖尿病(DM)和规律运动分为四组。主要不良事件包括主要肢体不良事件和主要心血管不良事件。采用Kaplan-Meier法评估无主要不良事件生存率,并使用Cox比例风险分析来分析主要不良事件的相关因素。

结果

Kaplan-Meier生存曲线显示,患有糖尿病且不经常运动的患者无主要不良事件生存期较短。Cox回归分析显示,对于严重肢体缺血或慢性肾脏病患者,主要不良事件风险增加,而分组变量无显著意义。

结论

对糖尿病、严重肢体缺血和慢性肾脏病患者进行目标管理,对于降低PAD患者血管内血运重建术后的主要不良事件至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7f4/9102344/e47dba9acd5c/jcm-11-02547-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7f4/9102344/e02c42bfac5f/jcm-11-02547-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7f4/9102344/e47dba9acd5c/jcm-11-02547-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7f4/9102344/e02c42bfac5f/jcm-11-02547-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7f4/9102344/e47dba9acd5c/jcm-11-02547-g002.jpg

相似文献

1
Major Adverse Events in Patients with Peripheral Artery Disease after Endovascular Revascularization: A Retrospective Study.血管腔内血运重建术后外周动脉疾病患者的主要不良事件:一项回顾性研究
J Clin Med. 2022 May 1;11(9):2547. doi: 10.3390/jcm11092547.
2
Metformin Is Associated with Improved Survival and Decreased Cardiac Events with No Impact on Patency and Limb Salvage after Revascularization for Peripheral Arterial Disease.二甲双胍与外周动脉疾病血运重建术后生存率提高、心脏事件减少相关,且对通畅率和肢体挽救无影响。
Ann Vasc Surg. 2019 Feb;55:63-77. doi: 10.1016/j.avsg.2018.05.054. Epub 2018 Aug 4.
3
Major Limb Outcomes Following Lower Extremity Endovascular Revascularization in Patients With and Without Diabetes Mellitus.糖尿病患者和非糖尿病患者下肢血管腔内血运重建后的主要肢体结局
J Endovasc Ther. 2017 Jun;24(3):376-382. doi: 10.1177/1526602817705135. Epub 2017 Apr 25.
4
Analysis of wound healing time and wound-free period as outcomes after surgical and endovascular revascularization for critical lower limb ischemia.分析手术和血管内再通治疗严重下肢缺血后伤口愈合时间和无伤口期作为结局的情况。
J Vasc Surg. 2018 Mar;67(3):817-825. doi: 10.1016/j.jvs.2017.07.122. Epub 2017 Oct 9.
5
High hemoglobin A associated with increased adverse limb events in peripheral arterial disease patients undergoing revascularization.血红蛋白 A 水平高与外周动脉疾病患者血运重建后不良肢体事件增加相关。
J Vasc Surg. 2018 Jan;67(1):217-228.e1. doi: 10.1016/j.jvs.2017.06.101. Epub 2017 Aug 31.
6
Patient and limb outcomes 10 years after endovascular revascularization of the superficial femoral artery for peripheral artery disease: The Boston Femoral Artery Endovascular Revascularization Outcomes (Boston FAROUT) study.患者和肢体结局 10 年后外周动脉疾病的股浅动脉腔内血管重建:波士顿股动脉腔内血管重建结局(Boston FAROUT)研究。
Vasc Med. 2023 Aug;28(4):290-298. doi: 10.1177/1358863X231174052. Epub 2023 May 21.
7
Severe inframalleolar disease is an independent predictor of adverse limb outcomes after endovascular revascularization in chronic limb-threatening ischemia.严重的内踝下疾病是慢性肢体威胁性缺血血管腔内血运重建术后肢体不良结局的独立预测因素。
J Vasc Surg. 2023 Mar;77(3):858-863. doi: 10.1016/j.jvs.2022.10.042. Epub 2022 Nov 1.
8
Outcomes of Endovascular Therapy for Upper Extremity Peripheral Artery Disease With Critical Hand Ischemia.伴有严重手部缺血的上肢外周动脉疾病的血管内治疗结果
J Endovasc Ther. 2016 Oct;23(5):717-22. doi: 10.1177/1526602816659279. Epub 2016 Jul 14.
9
Impact of geriatric nutritional risk index on prognosis in peripheral artery disease patients undergoing endovascular therapy.老年营养风险指数对行血管内治疗的外周动脉疾病患者预后的影响。
J Clin Hypertens (Greenwich). 2023 May;25(5):497-503. doi: 10.1111/jch.14659. Epub 2023 Apr 29.
10
Poorer limb salvage in African American men with chronic limb ischemia is due to advanced clinical stage and higher anatomic complexity at presentation.患有慢性肢体缺血的非裔美国男性肢体挽救率较低,原因是就诊时临床分期较晚且解剖结构复杂性较高。
J Vasc Surg. 2016 May;63(5):1318-24. doi: 10.1016/j.jvs.2015.11.052. Epub 2016 Mar 19.

引用本文的文献

1
Comparison of efficacy and safety of sarpogrelate-based anti-platelet therapy with non-sarpogrelate-based anti-platelet therapy following arterial endovascular therapy: a systematic review.动脉血管内治疗后基于沙格雷酯的抗血小板治疗与非基于沙格雷酯的抗血小板治疗的疗效和安全性比较:一项系统评价
Ann Med Surg (Lond). 2024 Aug 22;86(10):6071-6078. doi: 10.1097/MS9.0000000000002373. eCollection 2024 Oct.
2
In vitro PK/PD modeling of tyrosine kinase inhibitors in non-small cell lung cancer cell lines.在非小细胞肺癌细胞系中酪氨酸激酶抑制剂的体外 PK/PD 模型研究。
Clin Transl Sci. 2024 Mar;17(3):e13714. doi: 10.1111/cts.13714.
3

本文引用的文献

1
Functional Status and Health-Related Quality of Life in Patients with Peripheral Artery Disease: A Cross-Sectional Study.外周动脉疾病患者的功能状态和健康相关生活质量:一项横断面研究。
Int J Environ Res Public Health. 2021 Oct 18;18(20):10941. doi: 10.3390/ijerph182010941.
2
Association Between Wearable Device-Based Measures of Physical Frailty and Major Adverse Events Following Lower Extremity Revascularization.基于可穿戴设备的身体虚弱指标与下肢血运重建术后主要不良事件的关联。
JAMA Netw Open. 2020 Nov 2;3(11):e2020161. doi: 10.1001/jamanetworkopen.2020.20161.
3
Physical activity and exercise: Strategies to manage frailty.
Incidence and Prevalence of Peripheral Arterial Disease in South Korea: Retrospective Analysis of National Claims Data.
韩国外周动脉疾病的发病率和患病率:国家索赔数据分析的回顾性分析。
JMIR Public Health Surveill. 2022 Nov 18;8(11):e34908. doi: 10.2196/34908.
身体活动与锻炼:衰弱管理策略。
Redox Biol. 2020 Aug;35:101513. doi: 10.1016/j.redox.2020.101513. Epub 2020 Mar 20.
4
Association between Full Electronic Medical Record System Adoption and Drug Use: Antibiotics and Polypharmacy.全面采用电子病历系统与药物使用之间的关联:抗生素与多重用药
Healthc Inform Res. 2020 Jan;26(1):68-77. doi: 10.4258/hir.2020.26.1.68. Epub 2020 Jan 31.
5
Machine Learning and Initial Nursing Assessment-Based Triage System for Emergency Department.基于机器学习和初始护理评估的急诊科分诊系统
Healthc Inform Res. 2020 Jan;26(1):13-19. doi: 10.4258/hir.2020.26.1.13. Epub 2020 Jan 31.
6
Editor's Choice - Comorbidity Patterns Among Patients with Peripheral Arterial Occlusive Disease in Germany: A Trend Analysis of Health Insurance Claims Data.编辑精选 - 德国外周动脉阻塞性疾病患者的合并症模式:基于健康保险索赔数据的趋势分析。
Eur J Vasc Endovasc Surg. 2020 Jan;59(1):59-66. doi: 10.1016/j.ejvs.2019.08.006. Epub 2019 Nov 16.
7
Optimal Strategy for Antiplatelet Therapy After Endovascular Revascularization for Lower Extremity Peripheral Artery Disease.下肢外周动脉疾病血管内血运重建后抗血小板治疗的最佳策略。
JACC Cardiovasc Interv. 2019 Dec 9;12(23):2359-2370. doi: 10.1016/j.jcin.2019.08.006. Epub 2019 Nov 13.
8
Risk factors for asymptomatic peripheral arterial disease in Korean population: lessons from a community-based screening.韩国人群无症状外周动脉疾病的危险因素:基于社区筛查的经验教训。
Ann Surg Treat Res. 2019 Oct;97(4):210-216. doi: 10.4174/astr.2019.97.4.210. Epub 2019 Oct 1.
9
Risk factors and clinical outcomes in chronic coronary and peripheral artery disease: An analysis of the randomized, double-blind COMPASS trial.慢性冠状动脉和外周动脉疾病的风险因素和临床结局:对随机、双盲 COMPASS 试验的分析。
Eur J Prev Cardiol. 2020 Feb;27(3):296-307. doi: 10.1177/2047487319882154. Epub 2019 Oct 15.
10
Coronary artery disease and restenosis after peripheral endovascular intervention are predictors of poor outcome in peripheral arterial disease.冠状动脉疾病和外周血管腔内介入术后再狭窄是外周动脉疾病预后不良的预测因素。
Acta Cardiol. 2020 Nov;75(7):649-656. doi: 10.1080/00015385.2019.1653565. Epub 2019 Aug 15.